Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

July 01, 2006 (Vol. 26, No. 13)

CROs Become a Biotech Industry Staple

Users Cite Benefits of Accelerated Development, Cost Cutting, and Reliable Expertise

  • According to a recent report from the Tufts Center for the Study of Drug Development (January/February 2006 CSDD Impact Report), drug companies that are high users of CROs tend to complete projects faster than those with low usage. Without loss of quality, projects involving more CRO usage (greater than ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.